Medication nonadherence: a diagnosable and treatable medical condition.
about
Smartphone- and internet-assisted self-management and adherence tools to manage Parkinson's disease (SMART-PD): study protocol for a randomised controlled trial (v7; 15 August 2014).The impact of optimal medical therapy at discharge on mortality in patients with coronary artery disease.Behavior change, health, and health disparities: an introductionAmbiguity in determining financial capability of SSI and SSDI beneficiaries with psychiatric disabilitiesThe Malaysian Medication Adherence Scale (MALMAS): Concurrent Validity Using a Clinical Measure among People with Type 2 Diabetes in Malaysia.Determinants of medication adherence among adults with type 2 diabetes mellitus in three Malaysian public health clinics: a cross-sectional study.Ambulatory quality indicators to prevent infection in sickle cell disease.The impact of time-window bias on the assessment of the long-term effect of medication adherence: the case of secondary prevention after myocardial infarctionImpact of Non-Adherence on Renal and Cardiovascular Outcomes in US VeteransMedication Nonadherence Is Associated With Increased Subsequent Acute Care Utilization Among Medicaid Beneficiaries With Systemic Lupus Erythematosus.Adherence to antihypertensive medications: is prescribing the right pill enough?A randomized controlled trial to provide adherence information and motivational interviewing to improve diabetes and lipid control.Urinary antihypertensive drug metabolite screening using molecular networking coupled to high-resolution mass spectrometry fragmentationAn algorithm to identify medication nonpersistence using electronic pharmacy databases.Adherence to Glaucoma Medications Over 12 Months in Two US Community Pharmacy ChainsThe impact of adherence to inhaled drugs on 5-year survival in COPD patients: a time dependent approach.The ARMS-D out performs the SDSCA, but both are reliable, valid, and predict glycemic control.Adherence and health care costs.Systematic review and meta-analysis: Patient and programme impact of fixed-dose combination antiretroviral therapy.Electronic medication monitoring-informed counseling to improve adherence to combination anti-retroviral therapy and virologic treatment outcomes: a meta-analysis.The KTx360°-study: a multicenter, multisectoral, multimodal, telemedicine-based follow-up care model to improve care and reduce health-care costs after kidney transplantation in children and adults.Cost-related medication nonadherence among adolescent and young adult cancer survivors.Effectiveness of a multidisciplinary home-based medication review program in reducing healthcare utilization among older adult Singaporeans.90-90-90-Plus: Maintaining Adherence to Antiretroviral Therapies.Behavioral economic incentives to improve adherence to antiretroviral medication.Psychometric Properties of the Four-Item Morisky Green Levine Medication Adherence Scale among Atherosclerosis Risk in Communities (ARIC) Study Participants.A National Assessment of Medication Adherence to Statins by the Racial Composition of Neighborhoods.Prevalence and Predictors of Patient Nonadherence to Pharmacological Acute Pain Therapy at Home After Day Surgery: A Prospective Cohort Study.Adherence to controller asthma medications: 6-month prevalence across a US community pharmacy chain.Factors predicting self-reported medication low adherence in a large sample of adults in the US general population: a cross-sectional study.Optimal medical therapy is vital for patients with coronary artery disease and acute coronary syndromes regardless of revascularization strategy.Accuracy of a screening tool for medication adherence: A systematic review and meta-analysis of the Morisky Medication Adherence Scale-8.Are patients willing to participate in surveys?Closing the loop in person-centered care: patient experiences of a chronic kidney disease self-management intervention.Using deep learning to improve medication safety: the untapped potential of social media.Physician's Perception Versus Patient's Actual Incidence of Drug Non-adherence in Chronic Illnesses.Fixed-dose combination therapy to reduce the growing burden of cardiovascular disease in low- and middle-income countries: feasibility and challenges.Glucocorticoids in systemic sclerosis: patients' beliefs and treatment adherence.Can Patients Afford to Be Adherent to Expensive Oral Cancer Drugs?: Unintended Consequences of Pharmaceutical Development.Optimization of Drug Prescription and Medication Management in Older Adults with Cardiovascular Disease.
P2860
Q30612675-70D3A5D9-8B6B-4568-A8CD-BCEFA3203244Q33615444-2CB2D36B-2D99-4AFF-9FC9-BA0E826FA03FQ35112482-154E7CE6-FA9D-45FF-B6E3-CF1D0D44F1BBQ35471595-12F0C4F5-D61A-4BC5-B74E-637F01ABB0E9Q35536685-A9496BCF-CDE0-4019-AFED-48071D326D7FQ35592869-2E066912-C086-4114-BA68-600CF247BA6DQ35669123-77C54456-3172-4035-91FA-4A8D8EEBAAEBQ35739935-07356729-DE3C-4828-980D-343325D19B1DQ36148339-C7714F83-2429-4D94-BAF2-382981790E15Q36386474-934FC86E-8B44-4E8A-8C51-D6CA5A45458EQ36475160-21DBE2F0-EDCA-4B9D-AF6D-31C009358051Q36490060-54C33BBC-3569-4B0A-A591-151D7E20CE44Q37063195-FA4E16E1-7EB3-4628-926D-5FE0F83A4A17Q37229253-774DADBC-F327-4A11-B002-79DA1224EF30Q37290806-0A37990E-9E73-4C83-8664-37C7385DFFBFQ37456602-2EA6419C-0652-47AF-A81B-5E5DCED21643Q37561716-A9D637BE-4D64-4BCD-8F22-96BC84DB07E7Q37603117-12128274-1B83-4E77-BAAE-973E47794977Q38195928-E07FAD73-0AA5-464D-89A2-D44B91269F70Q38515374-5B7182EF-B236-429E-BDA6-9FECEB4E3C04Q38613731-EAAC221E-B329-49F0-B36D-CDBCA0D85E96Q38679187-C14F1602-B2C0-4196-8222-254B990A3ADBQ38704239-A13808B8-D642-4A33-A886-81B4E2CF351BQ38780710-EF185F3B-3E3C-424B-8798-F635A205A7FCQ38851164-6CFADF18-910B-4F52-9E30-E9B652334864Q39092792-61574505-BF1E-4271-86AD-D12C90200322Q40168078-88E991F4-1242-4A06-A677-5198962E7FC2Q40238099-7CA94DB7-CC56-4AE9-A898-C8DA628A9BDCQ40623715-7CA65784-1070-4A9A-9183-14BC6D14A9F5Q42145841-2885F017-9C48-4A89-99F8-9FBF5E8E93B4Q42361724-285961BC-1F8B-4A73-9D45-5BEFA4B2AC91Q44582090-0A87ED37-FF85-4EC9-AAAF-EBB963D9E4D9Q46815324-66237CD0-55D3-4040-8625-48A7EDD9544EQ47100022-B4255FA7-F87E-47E2-A356-01D95C2AE4F9Q47109104-C257E6C7-AC08-4471-99EB-A86C3737385BQ47549855-4DAB90D3-C82D-4D6E-B1AF-6524D95CD52EQ47874524-F127616A-B19C-46E0-B8D8-F9FFEF57D3CFQ48058216-4157AA38-33AB-48A3-9AA6-92D4A6A5547FQ50069897-89A7062E-BF08-4020-A8AB-70962D03E238Q50129309-83B95B1D-9E3A-47C5-8557-94EE5F1286FB
P2860
Medication nonadherence: a diagnosable and treatable medical condition.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Medication nonadherence: a diagnosable and treatable medical condition.
@en
Medication nonadherence: a diagnosable and treatable medical condition.
@nl
type
label
Medication nonadherence: a diagnosable and treatable medical condition.
@en
Medication nonadherence: a diagnosable and treatable medical condition.
@nl
prefLabel
Medication nonadherence: a diagnosable and treatable medical condition.
@en
Medication nonadherence: a diagnosable and treatable medical condition.
@nl
P2860
P356
P1476
Medication nonadherence: a diagnosable and treatable medical condition
@en
P2093
Mary Ann Sevick
Zachary A Marcum
P2860
P304
P356
10.1001/JAMA.2013.4638
P407
P577
2013-05-01T00:00:00Z